What is the primary consequence of using monotherapy instead of combination therapy for most brucellosis patients?
Answer
It significantly increases the chances of the infection returning (relapse).
The foundational principle of successful brucellosis management is the use of combination antibiotic therapy, typically involving two different drugs administered concurrently for an extended duration. Using monotherapy, meaning employing only a single antibiotic agent, is strongly discouraged precisely because it severely compromises the ability to eradicate the bacteria, especially given their tendency to reside intracellularly. This incomplete eradication pathway results directly in a significantly elevated risk of relapse, where the infection reappears after the initial treatment course is finished, thereby undermining the entire therapeutic effort.

Related Questions
What is the standard duration for the entirely oral Doxycycline plus Rifampin regimen for uncomplicated brucellosis?Why is Doxycycline generally avoided when treating brucellosis in pregnant individuals?What is the primary consequence of using monotherapy instead of combination therapy for most brucellosis patients?What is the preferred initial antibiotic strategy when treating brucellosis in pregnant individuals?What minimum duration is often required for antibiotic courses targeting skeletal or joint brucellosis such as spondylitis?When tracking recovery from brucellosis, what common interpretation pitfall surrounds post-treatment tube agglutination test results?For Brucella infection involving the central nervous system (CNS), what combination therapy is commonly extended beyond the standard six weeks?Which specific complication of brucellosis demands the most aggressive management approach, frequently requiring surgical intervention?What significant factor influences the choice between the Doxycycline/Rifampin regimen and the Doxycycline/Aminoglycoside regimen?In uncomplicated brucellosis treatment, what is the main disadvantage of the Doxycycline plus Aminoglycoside combination compared to the oral regimen?